ARCH Advanced Revascularization Symposium
A

Update on Pharmacology / Dual Anti-Platelet Therapy (DAPT) in the Cath Lab

By ARCH Advanced Revascularization Symposium FEATURING Amit Amin
By ARCH Advanced Revascularization Symposium FEATURING Amit Amin
62 views
August 4, 2017
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
28:11
Top Ten Topics in Clinical Cardiology 2021

Time to Retire Aspirin?

Feat. R. Mehran
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
07:10
American College of Cardiology

Ticagrelor with or without Aspirin in ACS after PCI (TICO)

Feat. P. Block, Y. Jang
11:07
Houston Methodist DeBakey Heart and Vascular Center

Aspirin & Primary Prevention: What Do the Guidelines Say?

Feat. M. Gulati
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
09:14
American College of Cardiology

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High…

Feat. V. Fuster, D. Itchhaporia, M. Mack, C. Albert, J. Grapsa
20:06
Canadian Collaborative Research Network

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Feat. M. Sabatine
14:20
ARCH Advanced Revascularization Symposium

Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines

Feat. D. A. Cox
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
57:14
Northwestern Medicine Cardiovascular Care

Stress Testing in the Real World

Feat. M. Eimer
25:26
The Texas Heart Institute

The Use of Coronary Artery Calcium Score to Determine Benefit of Asp…

Feat. E. Hernandez
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
37:35
Top Ten Topics in Clinical Cardiology 2022

Top 10 Coronary Interventional Trials of 2022

Feat. S. Sharma
16:34
AHA 2022 Conference Coverage

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

Feat. G. W. Stone
12:53
Scottsdale Interventional Forum 2018

What is the Optimal DAPT Duration?

Feat. R. Yeh
08:07
Houston Methodist DeBakey Heart and Vascular Center

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…

Feat. N. Kleiman
13:36
Houston Methodist DeBakey Heart and Vascular Center

Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy

Feat. J. Ferreiro
16:04
The 8th Annual Western New England Acute Cardiology Conference

Antiplatelet Therapy After STEMI

Feat. R. Mehran